Most proteins in the human body are difficult targets for small-molecule drugs. This problem may have been overcome with the discovery of molecules that induce protein degradation, suggesting fresh, modular approaches to drug discovery.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Neklesa, T. K. et al. Nature Chem. Biol. 7, 538–543 (2011).
Tae, H. S. et al. ChemBioChem 13, 538–541 (2012).
Long, M. J. C., Gollapalli, D. R. & Hedstrom, L. Chem. Biol. 19, 629–637 (2012).
Russ, A. P. & Lampel, S. Drug Discov. Today 10, 1607–1610 (2005).
Kauffman, M. G., Molineaux, C. J., Kirk, C. J. & Crews, C. M. in Cancer: Principles & Practice of Oncology (eds DeVita, V. T. Jr, Lawrence, T. S. & Rosenberg, S. A.) 441–449 (Lippincott Williams & Wilkins, 2011).
Schneekloth, J. S. Jr et al. J. Am. Chem. Soc. 126, 3748–3754 (2004).
Kleiner, R. E., Dumelin, C. E. & Liu, D. R. Chem. Soc. Rev. 40, 5707–5717 (2011).
Clark, M. A. et al. Nature Chem. Biol. 5, 647–654 (2009).
Rights and permissions
About this article
Cite this article
Neklesa, T., Crews, C. Greasy tags for protein removal. Nature 487, 308–309 (2012). https://doi.org/10.1038/487308a
This article is cited by
Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
Nature Reviews Clinical Oncology (2021)
Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective
Targeted Oncology (2021)
Discovery of a first-in-class EZH2 selective degrader
Nature Chemical Biology (2020)
Induced protein degradation: an emerging drug discovery paradigm
Nature Reviews Drug Discovery (2017)
Know your target, know your molecule
Nature Chemical Biology (2015)